Thrombocytopenia News and Research

RSS
Thrombocytopenia is a condition in which there is a lower-than-normal number of platelets in the blood. It may result in easy bruising and excessive bleeding from wounds or bleeding in mucous membranes and other tissues.
Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers

Experts endorse recommendations for restrictive blood transfusions

Experts endorse recommendations for restrictive blood transfusions

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

FDA grants accelerated approval to new treatment for mantle cell lymphoma

FDA grants accelerated approval to new treatment for mantle cell lymphoma

Biogen and Ionis awarded 2017 Prix Galien USA Award for SPINRAZA

Biogen and Ionis awarded 2017 Prix Galien USA Award for SPINRAZA

First-ever treatment for Merkel cell carcinoma receives approval in Japan

First-ever treatment for Merkel cell carcinoma receives approval in Japan

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Pfizer receives FDA approval for new therapy to treat adults and children with AML

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

Mice study reveals how natural killer cells in the placenta can cause miscarriages

Mice study reveals how natural killer cells in the placenta can cause miscarriages

UNC-Chapel Hill researchers find undesirable issues with widely-used drug screening tool

UNC-Chapel Hill researchers find undesirable issues with widely-used drug screening tool

New discovery may be key to stopping shortages of vital blood-clotting cells

New discovery may be key to stopping shortages of vital blood-clotting cells

Study: Use of white blood cell boosting drugs found to be safe during chemo-radiotherapy of lung cancer

Study: Use of white blood cell boosting drugs found to be safe during chemo-radiotherapy of lung cancer

Positive CHMP opinion recognizes efficacy of Biogen’s SPINRAZA for treatment of spinal muscular atrophy

Positive CHMP opinion recognizes efficacy of Biogen’s SPINRAZA for treatment of spinal muscular atrophy

FDA approves new maintenance therapy for recurrent cancers

FDA approves new maintenance therapy for recurrent cancers

Ionis announces FDA approval of first SMA drug in the U.S for pediatric and adult patients

Ionis announces FDA approval of first SMA drug in the U.S for pediatric and adult patients

FDA awards accelerated approval to new ovarian cancer drug

FDA awards accelerated approval to new ovarian cancer drug

Long-term clinical data, experience supports effectiveness of PRRT for treating neuroendocrine tumors

Long-term clinical data, experience supports effectiveness of PRRT for treating neuroendocrine tumors